Orchestra BioMed approves new cash bonus plan and equity policies for 2025

Orchestra BioMed Holdings, Inc.

CEO Hochman and President Sherman eligible for 80% base salary cash bonus; CFO Taylor eligible for 50%.
2025 goals include BACKBEAT enrollment, Virtue Sirolimus program milestones, pipeline/partnerships, financial objectives.
Stretch goals can boost bonus up to 60%; CFO bonus further adjustable up to 45% or zero on individual performance.
VP+ officers may elect equity as 100% options, 100% RSUs, or 50/50; RSUs vest over 3 years starting at 24 months.
Section 16 officers' RSU tax liabilities satisfied by share withholding, not market sales.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.